FDAnews Drug Daily Bulletin

Neurochem Licenses Alza Pain Drug

April 26, 2007
A A

Canadian drug firm Neuromed said Tuesday it has licensed the exclusive U.S. rights to the potential opioid pain drug Oros Hydromorphone from Alza.
UPI